Six-month outcomes from the Ventricular Catheter Ablation Study, the first-in-human evaluation of its FieldForce Ablation System for ventricular tachycardia (VT), have been published in Circulation.

NEW ORLEANS, LA—Two new studies, both presented recently at the American Heart Association 2025 Scientific Sessions, tackle the different sides of the risk-benefit equation when it comes to the use of ...